Publications by authors named "C Dosquet"
Cancers (Basel)
April 2020
Article Synopsis
- Myeloproliferative neoplasms (MPN) increase the risk of blood clots, and pegylated-interferon alpha (IFN) and hydroxyurea (HU) are common treatments for these conditions.
- The study examined how IFN and HU affect blood clotting markers in 85 MPN patients, finding that IFN treated patients had significantly elevated hemostatic markers compared to those not on treatment.
- The research suggests that IFN therapy has major and reversible effects on blood coagulation in MPN patients, but further studies are needed to explore its potential link to increased clotting risks.
